All news

• November 2011 - Call for 40 Beta-Testers interested in blind testing a new CHO technology for recombinant MAb and more.

  From Nov 15, 2011 until Feb 15, 2012

   

  Whether you are a scientist with a particular interest in innovative expression systems or looking for a competitive system to express your protein of interest, we hope you will be interested in our “experimental” approach.

  Read more

• August 2011 - Meet us at European Cancer Cluster Partnering, 14-16 September, Toulouse, France

  Do not hesitate to contat us at contact@gtptech.com or + 33 561 28 70 20 to schedule a meeting.

• June 2011 - Learn more about our study concerning SF9 insect cell lines and N-glycosylation

  In this recombinant project using supposedly identical insect cell lines, analysis revealed subtle differences in N-glycosylation profiles suspected to be at the origin of variations in later protein-protein interactions.

  Read more

• March 2011 - Meet GTP Technology at the 4th Annual Proteins Congress London, 4-5 April

  Dr. Herve Ginisty & Christopher Pease will be happy to discuss your recombinant challenges and potential contribution to your success.

  To make an appointment, please contact us at pease@gtptech.com or +33 5 61287020.

• November 2010 - Indicia and GTP Technology offer combined competencies to help you obtain the Ab-Ag you want

   

  When the antibody and the 'body' come together

  Antibodies are only as good as the antigens used to generated them. Put chances on your side by calling on combined expertise to develop the Ab-Ag package.
  If you'd rather focus on your research than on constructing projects that combine constraints from the immunisation process with those from the protein engineering, you can hand us the challenge.
  Indicia and GTP Technology each have over 10 years experience in this field and joined competencies to help you obtain the Ab-rAg you want.

  Read more

• September 2010 - Meet GTP Technology at PEGS Europe Conference, October 5-7, 2010, Hannover, Germany

  - Tuesday, 5 october @ 12:00: Assist to our presentation “How a strong expertise in target proteins expression can become an added value for bioprocess development”, Dr. Herve Ginisty, CSO

  - From 5-7 October: Meet us at our stand FO4-10 at Biotechnica, held in conjunction with PEGS

  Herve Ginisty, CSO and Severine Hountondji, Business Development Manager will be pleased to discuss your projects.

  To make an appointment, please contact us at hountondji@gtptech.com or +33 5 61287020

   

• August 2010 - GTP introduces significant improvements in continuous fermentation processes with L.lactis

  The company has introduced enhancements to induced expression and developed a constitutive promoter for continuous fermentation processes in L. lactis. In doing so it has overcome most of the difficulty of balancing translation/secretion in L. lactis.

  The system is finally better suited for production, in particular for therapeutic or vaccine-related proteins.

  For more information, Improvements in continuous fermentation processes with L. lactis

• June 2010 - Meet us at the 2nd biotechnology & healthcare Euro-regional meetings, 1 & 2 July 2010, Montpellier (France)

  Do not hesitate to contact us to schedule a meeting.

• April 2010 - GTP now offers a catalogue of recombinant proteins for research.

  With over 800 projects performed over the past 10 years, GTP Technology has developed a considerable know how in the production of proteins from various types and origins. To capitalize on this know-how, we have developed a catalogue of recombinant proteins for research.

  Read more

• February 2010 - GTP has been approved by the French Ministry "de l'Enseignement Supérieur et de la Recherche" for the "Credit Impot Recherche"

  This approval is valid for 2008, 2009 and 2010.
  The CIR allows French companies to declare innovative research costs and obtain a significant reduction on their tax bill.

• 1. 2.